CCDC18
gene geneOn this page
Also known as NY-SAR-41
Summary
CCDC18 (coiled-coil domain containing 18, HGNC:30370) is a protein-coding gene on chromosome 1p22.1, encoding Coiled-coil domain-containing protein 18 (Q5T9S5). May promote pre-adipocyte differentiation.
Located in centriolar satellite.
Source: NCBI Gene 343099 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 243 total — 1 pathogenic
- MANE Select transcript:
NM_001378204
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30370 |
| Approved symbol | CCDC18 |
| Name | coiled-coil domain containing 18 |
| Location | 1p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NY-SAR-41 |
| Ensembl gene | ENSG00000122483 |
| Ensembl biotype | protein_coding |
| OMIM | 621137 |
| Entrez | 343099 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 13 protein_coding, 5 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000343253, ENST00000370276, ENST00000401026, ENST00000421014, ENST00000447456, ENST00000448243, ENST00000455267, ENST00000479653, ENST00000481180, ENST00000528942, ENST00000688770, ENST00000690025, ENST00000690592, ENST00000692873, ENST00000935051, ENST00000935052, ENST00000935053, ENST00000935054, ENST00000935055, ENST00000956828, ENST00000956829
RefSeq mRNA: 3 — MANE Select: NM_001378204
NM_001306076, NM_001378204, NM_206886
CCDS: CCDS41356, CCDS76180, CCDS91004
Canonical transcript exons
ENST00000690025 — 29 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000831156 | 93236248 | 93236390 |
| ENSE00001333640 | 93239683 | 93239896 |
| ENSE00001452235 | 93278463 | 93278730 |
| ENSE00001452239 | 93270347 | 93270814 |
| ENSE00003490619 | 93264701 | 93264901 |
| ENSE00003495662 | 93254471 | 93254614 |
| ENSE00003500634 | 93221609 | 93221743 |
| ENSE00003509238 | 93192000 | 93192106 |
| ENSE00003531492 | 93205510 | 93205631 |
| ENSE00003533797 | 93183360 | 93183495 |
| ENSE00003549286 | 93207107 | 93207398 |
| ENSE00003560903 | 93232426 | 93232593 |
| ENSE00003573690 | 93214743 | 93214966 |
| ENSE00003583987 | 93186345 | 93186503 |
| ENSE00003590608 | 93212101 | 93212261 |
| ENSE00003594546 | 93258748 | 93258885 |
| ENSE00003594724 | 93217738 | 93217869 |
| ENSE00003595173 | 93201892 | 93201988 |
| ENSE00003597308 | 93256335 | 93256538 |
| ENSE00003604502 | 93183978 | 93184146 |
| ENSE00003606360 | 93239310 | 93239473 |
| ENSE00003636420 | 93226333 | 93226449 |
| ENSE00003653060 | 93246838 | 93246954 |
| ENSE00003661139 | 93210802 | 93210926 |
| ENSE00003665224 | 93221859 | 93221936 |
| ENSE00003665497 | 93193616 | 93193744 |
| ENSE00003673225 | 93216636 | 93216746 |
| ENSE00003684726 | 93246105 | 93246204 |
| ENSE00003936589 | 93180724 | 93180852 |
Expression profiles
Bgee: expression breadth ubiquitous, 171 present calls, max score 90.52.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.6146 / max 129.6984, expressed in 1516 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 4058 | 5.0900 | 1211 |
| 201577 | 1.2319 | 745 |
| 4057 | 0.2927 | 104 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.94 | gold quality |
| ventricular zone | UBERON:0003053 | 88.39 | gold quality |
| bone marrow cell | CL:0002092 | 84.86 | gold quality |
| left testis | UBERON:0004533 | 82.00 | gold quality |
| calcaneal tendon | UBERON:0003701 | 81.99 | gold quality |
| right testis | UBERON:0004534 | 81.66 | gold quality |
| oocyte | CL:0000023 | 81.62 | gold quality |
| testis | UBERON:0000473 | 81.57 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.61 | gold quality |
| monocyte | CL:0000576 | 80.33 | gold quality |
| granulocyte | CL:0000094 | 80.26 | gold quality |
| leukocyte | CL:0000738 | 80.06 | gold quality |
| right lobe of liver | UBERON:0001114 | 77.71 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.03 | gold quality |
| spleen | UBERON:0002106 | 77.02 | gold quality |
| colonic epithelium | UBERON:0000397 | 76.99 | gold quality |
| lymph node | UBERON:0000029 | 76.88 | gold quality |
| vermiform appendix | UBERON:0001154 | 76.82 | gold quality |
| gastrocnemius | UBERON:0001388 | 76.45 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.41 | gold quality |
| thymus | UBERON:0002370 | 75.89 | gold quality |
| muscle of leg | UBERON:0001383 | 75.86 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 75.24 | gold quality |
| tendon | UBERON:0000043 | 75.06 | gold quality |
| rectum | UBERON:0001052 | 75.05 | gold quality |
| right lung | UBERON:0002167 | 74.43 | gold quality |
| bone marrow | UBERON:0002371 | 74.25 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 74.25 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 74.10 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9543 | yes | 19.12 |
| E-CURD-112 | yes | 18.99 |
| E-ANND-3 | yes | 5.61 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting CCDC18, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-424-5P | 99.89 | 71.90 | 2641 |
| HSA-MIR-6838-5P | 99.89 | 71.94 | 2690 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-3154 | 98.94 | 66.55 | 1455 |
| HSA-MIR-556-5P | 97.75 | 66.17 | 473 |
| HSA-MIR-610 | 96.84 | 67.98 | 905 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc18 | ENSDARG00000078822 |
| danio_rerio | si:ch73-389b16.1 | ENSDARG00000101586 |
| mus_musculus | Ccdc18 | ENSMUSG00000056531 |
| rattus_norvegicus | Ccdc18 | ENSRNOG00000024545 |
Paralogs (2): DEUP1 (ENSG00000165325), CEP63 (ENSG00000182923)
Protein
Protein identifiers
Coiled-coil domain-containing protein 18 — Q5T9S5 (reviewed: Q5T9S5)
Alternative names: Sarcoma antigen NY-SAR-24
All UniProt accessions (11): A0A8I5KNM5, A0A8I5KRA2, A0A8I5KUE1, A0A8I5KWA2, E9PFB9, Q5T9S5, H0YCD6, H0YDP2, H7C0C9, J3KP97, Q5T9S2
UniProt curated annotations — full annotation on UniProt →
Function. May promote pre-adipocyte differentiation.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriolar satellite.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5T9S5-1 | 1 | yes |
| Q5T9S5-2 | 2 |
RefSeq proteins (3): NP_001293005, NP_001365133, NP_996769 (=MANE)
Domains & families (InterPro)
UniProt features (15 total): sequence conflict 6, coiled-coil region 4, modified residue 2, chain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5T9S5-F1 | 71.83 | 0.08 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 45, 1355
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 116 (showing top):
GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, FISCHER_DREAM_TARGETS, GOBP_CONNECTIVE_TISSUE_DEVELOPMENT, GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, chr1p22, GOBP_ADIPOSE_TISSUE_DEVELOPMENT, TGGAAA_NFAT_Q4_01, GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOCC_CENTRIOLAR_SATELLITE, GEORGES_TARGETS_OF_MIR192_AND_MIR215
GO Biological Process (1): positive regulation of adipose tissue development (GO:1904179)
GO Molecular Function (0):
GO Cellular Component (3): centriolar satellite (GO:0034451), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| positive regulation of developmental process | 1 |
| positive regulation of multicellular organismal process | 1 |
| adipose tissue development | 1 |
| regulation of adipose tissue development | 1 |
| centrosome | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
738 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC18 | CCDC14 | Q49A88 | 648 |
| CCDC18 | PRADC1 | Q9BSG0 | 588 |
| CCDC18 | KIAA0753 | Q2KHM9 | 521 |
| CCDC18 | PRSS37 | A4D1T9 | 509 |
| CCDC18 | CCDC13 | Q8IYE1 | 489 |
| CCDC18 | CEP126 | Q9P2H0 | 478 |
| CCDC18 | TMEM35B | Q8NCS4 | 478 |
| CCDC18 | KLHDC8A | Q8IYD2 | 477 |
| CCDC18 | CCDC12 | Q8WUD4 | 476 |
| CCDC18 | SFXN4 | Q6P4A7 | 471 |
| CCDC18 | UACA | Q9BZF9 | 470 |
| CCDC18 | NUDT7 | P0C024 | 464 |
| CCDC18 | TMEM71 | Q6P5X7 | 441 |
| CCDC18 | ZNF490 | Q9ULM2 | 430 |
| CCDC18 | CCDC66 | A2RUB6 | 423 |
IntAct
41 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED4 | MED19 | psi-mi:“MI:2364”(proximity) | 0.900 |
| PRPF19 | AQR | psi-mi:“MI:0914”(association) | 0.790 |
| DYNLL1 | BLTP3B | psi-mi:“MI:0914”(association) | 0.730 |
| GALK2 | POTEF | psi-mi:“MI:0914”(association) | 0.530 |
| EMILIN1 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| CDR2 | IGSF3 | psi-mi:“MI:0914”(association) | 0.530 |
| COG3 | TBCC | psi-mi:“MI:0914”(association) | 0.530 |
| NDEL1 | OFD1 | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC13 | CEP290 | psi-mi:“MI:0914”(association) | 0.460 |
| Cep135 | psi-mi:“MI:0914”(association) | 0.350 | |
| Ska1 | HSPD1 | psi-mi:“MI:0914”(association) | 0.350 |
| Cep131 | WBP2 | psi-mi:“MI:0914”(association) | 0.350 |
| OFD1 | CCDC14 | psi-mi:“MI:0914”(association) | 0.350 |
| Lrrcc1 | CCDC14 | psi-mi:“MI:0914”(association) | 0.350 |
| FAM167A | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| NDEL1 | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| SYCE1 | RABGAP1L | psi-mi:“MI:0914”(association) | 0.350 |
| BFSP1 | RABGAP1L | psi-mi:“MI:0914”(association) | 0.350 |
| COMT | AP1G1 | psi-mi:“MI:0914”(association) | 0.350 |
| CENPQ | ZFC3H1 | psi-mi:“MI:0914”(association) | 0.350 |
| GLRX | HPRT1 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP128 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| OFD1 | PSMD14 | psi-mi:“MI:2364”(proximity) | 0.270 |
| PCM1 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ODF2 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP135 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| POC5 | PSMD14 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP63 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| EYA2 | CNOT1 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (96): CCDC18 (Affinity Capture-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS)
ESM2 similar proteins: A6QR54, A8WG43, A9UM82, B2RZ86, B3DLE8, E9Q1U1, P0CAP1, Q08B20, Q08DR9, Q0VBY1, Q2T9U2, Q3SWS9, Q3UIJ9, Q4R7H3, Q4R8C3, Q53EZ4, Q5DTN8, Q5EB94, Q5M9N0, Q5PQ23, Q5RI56, Q5T9S5, Q5ZKK5, Q640L5, Q66H89, Q6NRC9, Q6NRW2, Q6P5D4, Q6TFL3, Q6ZU80, Q70FJ1, Q7ZW57, Q8BI22, Q8BVL9, Q8CDI6, Q8CDI7, Q8HYY4, Q8IUD2, Q8N998, Q8NCX0
Diamond homologs: Q5T9S5, Q640L5, Q9PW73
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 58 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Activation of BAD and translocation to mitochondria | 7 | 140.2× | 2e-12 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 7 | 123.8× | 3e-12 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 7 | 123.8× | 3e-12 |
| Activation of BH3-only proteins | 7 | 91.5× | 3e-11 |
| RHO GTPases activate PKNs | 7 | 58.4× | 5e-10 |
| Intrinsic Pathway for Apoptosis | 7 | 53.9× | 7e-10 |
| FOXO-mediated transcription | 5 | 44.2× | 8e-07 |
| Loss of Nlp from mitotic centrosomes | 9 | 37.6× | 5e-11 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| substantia nigra development | 6 | 43.1× | 1e-06 |
| protein targeting | 5 | 35.9× | 4e-05 |
| intracellular protein localization | 10 | 20.5× | 2e-08 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
243 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 169 |
| Likely benign | 20 |
| Benign | 17 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 151368 | GRCh38/hg38 1p22.1(chr1:92490929-93507291)x1 | Pathogenic |
SpliceAI
5317 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:93180052:A:AC | donor_gain | 1.0000 |
| 1:93180053:C:CT | donor_gain | 1.0000 |
| 1:93183357:A:AG | acceptor_gain | 1.0000 |
| 1:93183358:A:G | acceptor_gain | 1.0000 |
| 1:93183359:GAAAT:G | acceptor_gain | 1.0000 |
| 1:93183976:A:AG | acceptor_gain | 1.0000 |
| 1:93183977:G:GG | acceptor_gain | 1.0000 |
| 1:93186339:TTTCA:T | acceptor_loss | 1.0000 |
| 1:93186340:TTCAG:T | acceptor_loss | 1.0000 |
| 1:93186341:TCAGA:T | acceptor_loss | 1.0000 |
| 1:93186342:CA:C | acceptor_loss | 1.0000 |
| 1:93186343:A:AC | acceptor_loss | 1.0000 |
| 1:93186344:G:GT | acceptor_loss | 1.0000 |
| 1:93186344:GAT:G | acceptor_gain | 1.0000 |
| 1:93186504:G:GG | donor_gain | 1.0000 |
| 1:93191994:TTTTA:T | acceptor_loss | 1.0000 |
| 1:93191996:TTAG:T | acceptor_loss | 1.0000 |
| 1:93191997:TA:T | acceptor_loss | 1.0000 |
| 1:93191998:A:AG | acceptor_gain | 1.0000 |
| 1:93191999:G:GG | acceptor_gain | 1.0000 |
| 1:93192104:GAG:G | donor_gain | 1.0000 |
| 1:93192105:AGGT:A | donor_loss | 1.0000 |
| 1:93192106:GGTA:G | donor_loss | 1.0000 |
| 1:93192107:G:C | donor_loss | 1.0000 |
| 1:93192107:G:GG | donor_gain | 1.0000 |
| 1:93192108:T:A | donor_loss | 1.0000 |
| 1:93193613:T:G | acceptor_gain | 1.0000 |
| 1:93193613:TA:T | acceptor_loss | 1.0000 |
| 1:93193614:A:AG | acceptor_gain | 1.0000 |
| 1:93193614:AG:A | acceptor_loss | 1.0000 |
AlphaMissense
9740 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:93193620:G:C | A192P | 0.997 |
| 1:93201914:G:C | A241P | 0.997 |
| 1:93201926:G:C | A245P | 0.997 |
| 1:93214926:T:C | L559P | 0.997 |
| 1:93246185:T:C | L1020P | 0.997 |
| 1:93183447:T:C | L29P | 0.996 |
| 1:93246199:G:C | A1025P | 0.996 |
| 1:93201936:T:C | L248P | 0.995 |
| 1:93246164:T:C | L1013P | 0.995 |
| 1:93232511:T:C | L792P | 0.994 |
| 1:93239881:T:C | L988P | 0.993 |
| 1:93246196:G:C | A1024P | 0.993 |
| 1:93192075:G:C | A180P | 0.992 |
| 1:93201918:T:C | L242P | 0.992 |
| 1:93216679:T:C | L587P | 0.992 |
| 1:93226343:T:C | L728P | 0.992 |
| 1:93232448:T:C | L771P | 0.992 |
| 1:93239809:T:C | L964P | 0.992 |
| 1:93239830:T:C | L971P | 0.992 |
| 1:93201907:G:C | R238S | 0.991 |
| 1:93201907:G:T | R238S | 0.991 |
| 1:93232562:T:C | L809P | 0.991 |
| 1:93236270:T:C | L827P | 0.991 |
| 1:93239893:T:C | L992P | 0.991 |
| 1:93193633:T:C | L196P | 0.990 |
| 1:93214830:T:C | L527P | 0.990 |
| 1:93214842:T:C | L531P | 0.990 |
| 1:93216667:T:C | L583P | 0.990 |
| 1:93246195:A:C | R1023S | 0.990 |
| 1:93246195:A:T | R1023S | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000006426 (1:93224022 C>A), RS1000027098 (1:93212537 A>G), RS1000038747 (1:93212873 A>G), RS1000054194 (1:93262740 C>T), RS1000210042 (1:93228044 A>G), RS1000241019 (1:93228312 G>A), RS1000270723 (1:93179014 C>G), RS1000321081 (1:93259611 G>T), RS1000419562 (1:93204728 C>T), RS1000431545 (1:93262176 C>T), RS1000445489 (1:93185778 A>G), RS1000456892 (1:93186079 G>A), RS1000478785 (1:93252773 C>T), RS1000485068 (1:93234901 T>G), RS1000545849 (1:93226635 G>A,C)
Disease associations
OMIM: gene MIM:621137 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004600_64 | Eosinophil percentage of white cells | 3.000000e-11 |
| GCST004606_168 | Eosinophil count | 1.000000e-12 |
| GCST004617_56 | Eosinophil percentage of granulocytes | 2.000000e-10 |
| GCST004623_148 | Neutrophil percentage of granulocytes | 7.000000e-10 |
| GCST004624_194 | Sum eosinophil basophil counts | 8.000000e-12 |
| GCST007733_30 | Serum uric acid levels | 5.000000e-07 |
| GCST008477_35 | Emphysema annual change measurement in smokers (adjusted lung density) | 5.000000e-06 |
| GCST90002402_483 | Platelet count | 9.000000e-12 |
EFO canonical traits (8, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007991 | eosinophil percentage of leukocytes |
| EFO:0004842 | eosinophil count |
| EFO:0007996 | eosinophil percentage of granulocytes |
| EFO:0007994 | neutrophil percentage of granulocytes |
| EFO:0005090 | basophil count |
| EFO:0004761 | uric acid measurement |
| EFO:0007626 | emphysema imaging measurement |
| EFO:0004309 | platelet count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
54 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| trichostatin A | affects cotreatment, decreases expression, increases expression | 3 |
| Valproic Acid | increases expression, decreases expression | 3 |
| Cyclosporine | decreases expression, increases expression | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| Cadmium Chloride | increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | decreases expression | 1 |
| sulforaphane | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| 1-nitropyrene | increases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| microcystin RR | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| 2,2’,4,4’,5-brominated diphenyl ether | decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.